Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.
2.

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S.

Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9. Review.

3.

The SARS-CoV S glycoprotein.

Xiao X, Dimitrov DS.

Cell Mol Life Sci. 2004 Oct;61(19-20):2428-30. Review.

PMID:
15526150
4.

Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Graham RL, Baric RS.

J Virol. 2010 Apr;84(7):3134-46. doi: 10.1128/JVI.01394-09. Epub 2009 Nov 11. Review.

5.

Vaccine design for severe acute respiratory syndrome coronavirus.

He Y, Jiang S.

Viral Immunol. 2005;18(2):327-32. Review.

PMID:
16035944
6.

SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission.

Bolles M, Donaldson E, Baric R.

Curr Opin Virol. 2011 Dec;1(6):624-34. doi: 10.1016/j.coviro.2011.10.012. Review.

7.

Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity.

Badani H, Garry RF, Wimley WC.

Biochim Biophys Acta. 2014 Sep;1838(9):2180-97. doi: 10.1016/j.bbamem.2014.04.015. Epub 2014 Apr 26. Review.

8.

Site directed mutagenesis of the murine coronavirus spike protein. Effects on fusion.

Bos EC, Heijnen L, Spaan WJ.

Adv Exp Med Biol. 1995;380:283-6. Review.

PMID:
8830493
9.

Mechanisms of coronavirus cell entry mediated by the viral spike protein.

Belouzard S, Millet JK, Licitra BN, Whittaker GR.

Viruses. 2012 Jun;4(6):1011-33. doi: 10.3390/v4061011. Epub 2012 Jun 20. Review.

10.

The impact of influenza hemagglutinin fusion peptide length and viral subtype on its structure and dynamics.

Lorieau JL, Louis JM, Bax A.

Biopolymers. 2013 Mar;99(3):189-95. doi: 10.1002/bip.22102. Epub 2012 Sep 26. Review.

11.

Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission.

Lorizate M, Huarte N, Sáez-Cirión A, Nieva JL.

Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1624-39. doi: 10.1016/j.bbamem.2007.12.018. Epub 2008 Jan 3. Review.

12.

Common properties of fusion peptides from diverse systems.

Martin I, Ruysschaert JM.

Biosci Rep. 2000 Dec;20(6):483-500. Review.

PMID:
11426690
13.

Viral fusion proteins: multiple regions contribute to membrane fusion.

Peisajovich SG, Shai Y.

Biochim Biophys Acta. 2003 Jul 11;1614(1):122-9. Review.

14.

The many mechanisms of viral membrane fusion proteins.

Earp LJ, Delos SE, Park HE, White JM.

Curr Top Microbiol Immunol. 2005;285:25-66. Review.

PMID:
15609500
15.

Viral fusion peptides: a tool set to disrupt and connect biological membranes.

Tamm LK, Han X.

Biosci Rep. 2000 Dec;20(6):501-18. Review.

PMID:
11426691
16.

Lipids as modulators of membrane fusion mediated by viral fusion proteins.

Teissier E, Pécheur EI.

Eur Biophys J. 2007 Nov;36(8):887-99. Epub 2007 Sep 19. Review.

PMID:
17882414
17.

Class II fusion proteins.

Modis Y.

Adv Exp Med Biol. 2013;790:150-66. doi: 10.1007/978-1-4614-7651-1_8. Review.

PMID:
23884590
18.

Class III viral membrane fusion proteins.

Backovic M, Jardetzky TS.

Adv Exp Med Biol. 2011;714:91-101. doi: 10.1007/978-94-007-0782-5_3. Review.

PMID:
21506008
19.

The three lives of viral fusion peptides.

Apellániz B, Huarte N, Largo E, Nieva JL.

Chem Phys Lipids. 2014 Jul;181:40-55. doi: 10.1016/j.chemphyslip.2014.03.003. Epub 2014 Apr 2. Review.

20.

Relating structure to evolution in class II viral membrane fusion proteins.

Modis Y.

Curr Opin Virol. 2014 Apr;5:34-41. doi: 10.1016/j.coviro.2014.01.009. Epub 2014 Feb 11. Review.

Supplemental Content

Support Center